Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus has long been recognized as an important pathogen in human disease. Due to an increasing number of infections caused by methicillin-resistant S. aureus (MRSA) strains, therapy has become problematic. Therefore, prevention of staphylococcal infections has become more important. Carriage of S. aureus appears to play a key role in the epidemiology and pathogenesis of infection. The ecological niches of S. aureus are the anterior nares. In healthy subjects, over time, three patterns of carriage can be distinguished: about 20% of people are persistent carriers, 60% are intermittent carriers, and approximately 20% almost never carry S. aureus. The molecular basis of the carrier state remains to be elucidated. In patients who repeatedly puncture the skin (e.g., hemodialysis or continuous ambulatory peritoneal dialysis [CAPD] patients and intravenous drug addicts) and patients with human immunodeficiency virus (HIV) infection, increased carriage rates are found. Carriage has been identified as an important risk factor for infection in patients undergoing surgery, those on hemodialysis or CAPD, those with HIV infection and AIDS, those with intravascular devices, and those colonized with MRSA. Elimination of carriage has been found to reduce the infection rates in surgical patients and those on hemodialysis and CAPD. Elimination of carriage appears to be an attractive preventive strategy in patients at risk. Further studies are needed to optimize this strategy and to define the groups at risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People who misuse drugs have a higher rate of nasal or skin colonization with S. aureus than the general population (2, 14).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“Carriage of S. aureus is a significant risk factor for nosocomial invasive infections by S. aureus (Kluytmans et al., 1997).”
From Nasal Microenvironments and Interspecific Interactions Influence Nasal Microbiota Complexity and S. aureus Carriage (2013) · cites this paper as Kluytmans et al., 1997
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286 · cited 1×
“In 1992, resistance had increased to nearly 8% (66).”
BackgroundThe Spectrum of Vasculitis: Clinical, Pathologic, Immunologic, and Therapeutic Considerations
FAUCI, A. S., HAYNES, B. F., & KATZ, P. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-660 · Cited by 1,196 · cited 1×
“Wegener’s granulomatosis is a systemic disease characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract in combination with vasculitis and focal necrotizing crescentic glomerulonephritis (52).”
BackgroundMSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109 · cited 1×
“aureus is the second most prevalent organism causing intravascular device-associated bacteremia (111, 165).”
BackgroundMethicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Stegeman, C. A., Tervaert, J. W. C., Sluiter, W. J., Manson, W. L., de Jong, P. E., & Kallenberg, C. G. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00003 · Cited by 729
Prevention and Control of Nosocomial Infections.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-791_4 · Cited by 719
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Cited by
Items 101–200 of 1,002
O'Brien, L. M., Walsh, E. J., Massey, R. C., Peacock, S. J., & Foster, T. J. (2002) · Cellular Microbiology · doi:10.1046/j.1462-5822.2002.00231.x · Cited by 231
“Approximately 20% of the population persistently carry S. aureus at this site, whereas about 60% of individuals are intermittent carriers (Kluytmans, 1997).”
BackgroundMersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model
Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S. O., & Ljungh, Å. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh387 · Cited by 231
“aureus with a significantly higher risk for the development of staphylococcal diseases.(5) – 8 Thus, the need to introduce effective bactericidal substances for treatment of nasal carriage and therapy of MRSA infections is pressing.”
BackgroundMcCarthy, A. J., & Lindsay, J. A. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-173 · Cited by 230
“In humans 20% of a healthy population are persistently colonised in the anterior nares of the nose and a further 60% are intermittently colonised [1].”
BackgroundCorrigan, R. M., Miajlovic, H., & Foster, T. J. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-22 · Cited by 226
“aureus permanently in their noses and another 60% of individuals are intermittent carriers [1].”
BackgroundDeterminants of Staphylococcus aureus Nasal Carriage
Cole, A. M., Tahk, S., Oren, A., Yoshioka, D., Kim, Y.-H., Park, A., & Ganz, T. (2001) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.6.1064-1069.2001 · Cited by 225
“Nasal Staphylococcus aureus carriage, affecting about 20% of the population, has been identified as a risk factor for the pathogenesis of community-acquired and nosocomial infections (5, 12).”
BackgroundHaddad Kashani, H., Schmelcher, M., Sabzalipoor, H., Seyed Hosseini, E., & Moniri, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00071-17 · Cited by 225
“no threat to the host species under normal circumstances (5).”
BackgroundEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Brady, R. A., Leid, J. G., Camper, A. K., Costerton, J. W., & Shirtliff, M. E. (2006) · Infection and Immunity · doi:10.1128/iai.00392-06 · Cited by 222
“aureus is a normal commensal organism of the human nostrils; approximately 20% of the population are colonized with this bacterium, while 60% of the population are transient carriers (43).”
BackgroundLindsay, J. A., & Holden, M. T. G. (2006) · Functional & Integrative Genomics · doi:10.1007/s10142-005-0019-7 · Cited by 221
“aureus is a persistent resident of the human nose in 20% of the population and intermittently carried by another 60% (Kluytmans et al. 1997).”
BackgroundPractical Guidance for Clinical Microbiology Laboratories: Diagnosis of Bacterial Gastroenteritis
Humphries, R. M., & Linscott, A. J. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00073-14 · Cited by 219
Roche, F. M., Meehan, M., & Foster, T. J. (2003) · Microbiology · doi:10.1099/mic.0.26412-0 · Cited by 218
“Nasal carriage of S. aureus is considered to be a key risk factor for development of staphylococcal infection in the community and hospital (Kluytmans et al., 1997; Peacock et al., 2001).”
BackgroundNathwani, D., Morgan, M., Masterton, R. G., Dryden, M., Cookson, B. D., French, G., & Lewis, D. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn096 · Cited by 217
“aureus infection than MSSA carriage.(103) The risk over an 18 month period of MRSA infection among adult patients harbouring MRSA has been shown to be 29%,(104) with 28% of them complicated by bacteraemia and 56% by pneumonia, soft tissue infection, osteomyelitis or septic arthritis.”
Backgroundden Heijer, C. D., van Bijnen, E. M., Paget, W. J., Pringle, M., Goossens, H., Bruggeman, C. A., Schellevis, F. G., & Stobberingh, E. E. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70036-7 · Cited by 216
Persistence of Livestock Associated MRSA CC398 in Humans Is Dependent on Intensity of Animal Contact
Graveland, H., Wagenaar, J. A., Bergs, K., Heesterbeek, H., & Heederik, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016830 · Cited by 213
“than 1 year) ranges between 10–20% [1, 14, 17, 18].”
BackgroundWithin-Host Evolution of Staphylococcus aureus during Asymptomatic Carriage
Golubchik, T., Batty, E. M., Miller, R. R., Farr, H., Young, B. C., Larner-Svensson, H., Fung, R., Godwin, H., Knox, K., Votintseva, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061319 · Cited by 212
“aureus is frequently intermittent [54,55], we modeled these demographic changes using a model that captures the dynamics of colonization, establishment and eventual clearance.”
BackgroundMethodKoch, G., Yepes, A., Förstner, K. U., Wermser, C., Stengel, S. T., Modamio, J., Ohlsen, K., Foster, K. R., & Lopez, D. (2014) · Cell · doi:10.1016/j.cell.2014.06.046 · Cited by 211
“aureus is not exclusively a pathogen and commonly colonizes the nasopharynx and skin (Kluytmans et al., 1997).”
Backgroundvan Rijen, M. M. L., Bonten, M., Wenzel, R. P., & Kluytmans, J. A. J. W. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm480 · Cited by 207
“– 9 Based on these findings, eradication of nasal carriage to reduce infection rates has been studied.(8) Mupirocin nasal ointment has often been used to eradicate carriage because of its effectiveness, safety and low costs.”
BackgroundSelf-citationA Preoperative Decolonization Protocol for Staphylococcus aureus Prevents Orthopaedic Infections
Rao, N., Cannella, B., Crossett, L. S., Yates, A. J., & McGough, R. (2008) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-008-0225-4 · Cited by 206
“Being a carrier is an independent risk factor for orthopaedic surgical site infection (SSI) [11, 22, 31].”
BackgroundLepelletier, D., Maillard, J. Y., Pozzetto, B., & Simon, A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00682-20 · Cited by 205
“It is estimated that approximately 20% of the general population are permanent nasal carriers of S. aureus (9, 10).”
BackgroundMethicillin and vancomycin resistant S. aureus in hospitalized patients
Loomba, P., Taneja, J., & Mishra, B. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.68535 · Cited by 205
“Carrier rates close to 60% have been described previously for certain populations.[46] The throat has been considered as an important carriage site for S.”
BackgroundJenkins, A., Diep, B. A., Mai, T. T., Vo, N. H., Warrener, P., Suzich, J., Stover, C. K., & Sellman, B. R. (2015) · mBio · doi:10.1128/mbio.02272-14 · Cited by 203
Keane, W. F., Alexander, S. R., Bailie, G. R., Boeschoten, E., Gokal, R., Golper, T. A., Holmes, C. J., Huang, C.-C., Kawaguchi, Y., Piraino, B., et al. (1996) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.1177/089686089601600606 · Cited by 202
Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior Nares
Nilsson, P., & Ripa, T. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00880-06 · Cited by 200
“aureus infections (11), prophylactic decolonization of carriers has been tried with different patient groups (12).”
BackgroundInfluentialEarly Onset Pneumonia: Risk Factors and Consequences in Head Trauma Patients
Bronchard, R., Albaladejo, P., Brezac, G., Geffroy, A., Seince, P.-F., Morris, W., Branger, C., & Marty, J. (2004) · Anesthesiology · doi:10.1097/00000542-200402000-00009 · Cited by 197
“rate usually reported in the general population or in patients at admission.(16) The incidence of early onset”
BackgroundKluytmans, J. A. J. W. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03110.x · Cited by 196
“patients on dialysis, patients with human immunodeficiency virus, patients with organ transplants, patients with Wegener’s granulomatosis, patients in the intensive-care unit, or patients with intravascular catheters) [13].”
BackgroundSelf-citationChen, A. F., Wessel, C. B., & Rao, N. (2013) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-013-2875-0 · Cited by 196
“aureus (MSSA/MRSA) infection develop [31], it is important to find ways to reduce S.”
BackgroundLuo, S.-C., Wei, S., Luo, X.-T., Yang, Q.-Q., Wong, K., Cheung, P. C. K., & Zhang, B. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00488-7 · Cited by 201
“To a certain extent, S. mutans creates a lactic acid-rich environment in carious lesions that facilitates the proliferation of Veillonella species 12 , which have been shown to promote the growth of S. mutans in bio fi lm studies 24 .”
BackgroundAires de Sousa, M., & Lencastre, H. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00370-5 · Cited by 195
“aureus persistently, V60% intermittently and V20% never carry this bacterium [1].”
BackgroundInfluentialThe who, where, and when of IgE in allergic airway disease
Dullaers, M., De Bruyne, R., Ramadani, F., Gould, H. J., Gevaert, P., & Lambrecht, B. N. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.029 · Cited by 194
Schlievert, P. M., Strandberg, K. L., Lin, Y.-C., Peterson, M. L., & Leung, D. Y. M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.039 · Cited by 194
Gnanamani, A., Periasamy, H., & Satyaseela, M. P. (2017) · InTech eBooks · doi:10.5772/67338 · Cited by 198
“Methods such as local application of antibiotics (eg. mupirocin) or disinfectants, administration of systemic antibiotics and use of a harmless S. aureus strain (type 502A) which competes for the colonization of nares with existing one are employed to decolonize the S. aureus from nares [25–28].”
MethodPerl, T. M., & Golub, J. E. (1998) · Annals of Pharmacotherapy · doi:10.1177/106002809803200104 · Cited by 193
Smith, D. L., Dushoff, J., Perencevich, E. N., Harris, A. D., & Levin, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400456101 · Cited by 192
Rao, N., Cannella, B. A., Crossett, L. S., Yates, A. J., McGough, R. L., & Hamilton, C. W. (2011) · The Journal of Arthroplasty · doi:10.1016/j.arth.2011.03.014 · Cited by 191
“Nasal carriage of S aureus is epidemiologically linked to development of S aureus SSI [10-12] and was the only independent risk factor for S aureus SSI after orthopedic implant surgery in one study [13].”
BackgroundStaphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention
Dayan, G. H., Mohamed, N., Scully, I. L., Cooper, D., Begier, E., Eiden, J., Jansen, K. U., Gurtman, A., & Anderson, A. S. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1179583 · Cited by 154
“aureus with three distinct patterns of nasal colonization identified in the general population: persistent carriers (~20%), intermittent carriers (~30%), and non-carriers (~50%) [123,124,130].”
BackgroundThe Pathogenesis of Staphylococcus aureus Eye Infections
O’Callaghan, R. J. (2018) · Pathogens · doi:10.3390/pathogens7010009 · Cited by 191
“Approximately 35% of the general public and 50–66% of hospital workers become colonized with the organism [9,10].”
BackgroundBacterial chondronecrosis with osteomyelitis ('femoral head necrosis') of broiler chickens: A review
McNamee, P. T., Smyth, J. A., & Smyth, J. A. (2000) · Avian Pathology · doi:10.1080/03079450050118386 · Cited by 190
“One strategy that has been successfully used to prevent virulent staphylococcal infection both in human nurseries (Kluytmans et al., 1997) and in turkey flocks (Jensen et al., 1987) is bacterial interference.”
BackgroundWieler, L. H., Ewers, C., Guenther, S., Walther, B., & Lübke-Becker, A. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.09.009 · Cited by 188
Ohara-Nemoto, Y., Haraga, H., Kimura, S., & Nemoto, T. K. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47561-0 · Cited by 185
“Staphylococci are common residents of nasal flora (Wenzel & Perl 1995; Kluytmas et al., 1997; Güçlü et al., 2007), thus they may consistently pass into the mouth.”
BackgroundKaraolis, D. K. R., Rashid, M. H., Chythanya, R., Luo, W., Hyodo, M., & Hayakawa, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1029-1038.2005 · Cited by 153
“Staphylococcus aureus is an important human and animal pathogen (2, 21, 27, 57).”
BackgroundMRSA prevalence in european healthcare settings: a review
Dulon, M., Haamann, F., Peters, C., Schablon, A., & Nienhaus, A. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-138 · Cited by 184
“The anterior nares are considered to be the primary colonization site for S. aureus [1,21].”
BackgroundZollner, Wichelhaus, Hartung, Mallinckrodt, V., Wagner, Brade, & Kaufmann (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00848.x · Cited by 183
Yang, E. S., Tan, J., Eells, S., Rieg, G., Tagudar, G., & Miller, L. G. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02836.x · Cited by 183
“Previous investigations [16], which have rarely focused on CA-MRSA, have found that S.”
BackgroundVancomycin Resistance in Enterococcus and Staphylococcus aureus
Li, G., Walker, M. J., & Oliveira, D. M. P. D. (2022) · Microorganisms · doi:10.3390/microorganisms11010024 · Cited by 182
Determinants of Acquisition and Carriage of Staphylococcus aureus in Infancy
Peacock, S. J., Justice, A., Griffiths, D., de Silva, G. D. I., Kantzanou, M. N., Crook, D., Sleeman, K., & Day, N. P. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5718-5725.2003 · Cited by 181
“Three patterns of carriage have been described in adults, with approximately 20% of individuals being termed persistent noncarriers, 20% termed persistent carriers, and the remainder termed intermittent carriers (11).”
BackgroundCoates, T., Bax, R., & Coates, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp159 · Cited by 181
The challenge of antibiotic resistance: need to contemplate.
Kapil, A. (2005) · PubMed · Cited by 180
Kinkel, T. L., Roux, C. M., Dunman, P. M., & Fang, F. C. (2013) · mBio · doi:10.1128/mbio.00696-13 · Cited by 179
“The ubiquitous human pathogen Staphylococcus aureus commonly resides in the nose and on the skin, two sites at which nitric oxide (NO·) is produced in ample quantities by the host (1, 2).”
BackgroundTuzen, M., Karaman, I., Citak, D., & Soylak, M. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.04.024 · Cited by 179
“About 20% of the populations are long-term carriers of S. aureus (Kluytmans et al., 1997).”
BackgroundInsights into bactericidal action of surface-attached poly(vinyl-N-hexylpyridinium) chains
Lin, J., Tiller, J. C., Lee, S. B., Lewis, K., & Klibanov, A. M. (2002) · Biotechnology Letters · doi:10.1023/a:1015584423358 · Cited by 179
“Toward this end, in addition to the heretofore used wild strain of S. aureus (ATCC 33807), we explored three different antibiotic-resistant strains ( Kluytmans et al. 1997 ) – ATCC 700698 (resistant to methicillin), ATCC BAA-38 (resistant to methicillin, penicillin, streptomycin, and tetracycline), and ATCC BAA-39 (re…”
MethodVerkaik, N. J., de Vogel, C. P., Boelens, H. A., Grumann, D., Hoogenboezem, T., Vink, C., Hooijkaas, H., Foster, T. J., Verbrugh, H. A., van Belkum, A., et al. (2009) · Journal of Infectious Diseases · doi:10.1086/596743 · Cited by 178
“aureus, comprising ~20% of the healthy population [2, 3], have an increased risk of developing such infections [4-6], including a 3-fold higher risk of acquiring S.”
BackgroundSelf-citationCampillo, B., Richardet, J., Kheo, T., & Dupeyron, C. (2002) · Clinical Infectious Diseases · doi:10.1086/340617 · Cited by 177
“aureus appears to play a key role in the epidemiology and pathogenesis of infection and may account for the recurrence of infections at multiple sites [14, 15].”
BackgroundAntimicrobial Resistance in Commensal Flora of Pig Farmers
Aubry-Damon, H., Grenet, K., Sall-Ndiaye, P., Che, D., Cordeiro, E., Bougnoux, M.-E., Rigaud, E., Le Strat, Y., Lemanissier, V., Armand-Lefèvre, L., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1005.030735 · Cited by 140
“aureus nasal carriage in nonfarmers was similar to that reported previously in the general population (28), which suggests that the higher isolation rate in pig farmers was due to their work environment.”
ResultThe culturome of the human nose habitats reveals individual bacterial fingerprint patterns
Kaspar, U., Kriegeskorte, A., Schubert, T., Peters, G., Rudack, C., Pieper, D. H., Wos‐Oxley, M., & Becker, K. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.12891 · Cited by 175
“Though the species mostly 52 acts as an asymptomatic commensal in the nose, its colonisation can be source and risk factor for 53 subsequent infections (Kluytmans et al., 1997; von Eiff et al., 2001; Wertheim et al., 2004).”
BackgroundCastro, S. L., Nelman-Gonzalez, M., Nickerson, C. A., & Ott, C. M. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00175-11 · Cited by 134
New epidemiology of Staphylococcus aureus infection in Africa
Schaumburg, F., Alabi, A. S., Peters, G., & Becker, K. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12690 · Cited by 174
Schaffer, A. C., Solinga, R. M., Cocchiaro, J., Portoles, M., Kiser, K. B., Risley, A., Randall, S. M., Valtulina, V., Speziale, P., Walsh, E., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.4.2145-2153.2006 · Cited by 174
“These populations include patients with diabetes, eczema, and human immunodeficiency virus infection, individuals receiving continuous ambulatory peritoneal dialysis or hemodialysis, and injection drug users (19).”
BackgroundPrice, J. R., Golubchik, T., Cole, K., Wilson, D. J., Crook, D. W., Thwaites, G. E., Bowden, R. J., Walker, A. S., Peto, T., Paul, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit807 · Cited by 174
“Previous studies report rates between 14% and 53% among hospitalized patients [26, 27], with higher rates (18%–46%) in high-dependency settings [28].”
BackgroundSkin Microbiome in Atopic Dermatitis
Edslev, S., Agner, T., & Andersen, P. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3514 · Cited by 173
“aureus in both healthy and AD individuals (6, 38), was not considered to be a risk factor for AD development among infants with familial predisposition (39).”
BackgroundMethicillin-resistant Staphylococcus aureus in people living and working in pig farms
VAN DEN BROEK, I. V. F., VAN CLEEF, B. A. G. L., HAENEN, A., BROENS, E. M., VAN DER WOLF, P. J., VAN DEN BROEK, M. J. M., HUIJSDENS, X. W., KLUYTMANS, J. A. J. W., VAN DE GIESSEN, A. W., & TIEMERSMA, E. W. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808001507 · Cited by 172
Self-citationStaphylococcus aureus (Including Staphylococcal Toxic Shock)
QUE, Y.-A., & MOREILLON, P. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00195-8 · Cited by 172
Sikorska, H., & Smoragiewicz, W. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.003 · Cited by 172
Gurung, R. R., Maharjan, P., & Ganga, G. C. (2020) · Future Science OA · doi:10.2144/fsoa-2019-0122 · Cited by 174
“Moreover 60% population carries it occasionally during their life-time [2, 3].”
BackgroundNouwen, J. L., Fieren, M. W. J. A., Snijders, S. V., Verbrugh, H. A., & van Belkum, A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00174.x · Cited by 171
“aureus infections in persistent carriers were of endogenous origin [3, 53].”
BackgroundSelf-citationNovel Chromosomally Encoded Multidrug Efflux Transporter MdeA in Staphylococcus aureus
Huang, J., O'Toole, P. W., Shen, W., Amrine-Madsen, H., Jiang, X., Lobo, N., Palmer, L. M., Voelker, L., Fan, F., Gwynn, M. N., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.909-917.2004 · Cited by 151
Spread of Staphylococcus aureus in Hospitals: Causes and Prevention
Solberg, C. O. (2000) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655400459478 · Cited by 170
“Treatment of S. aureus carriers with topical nasal antibiotics and sometimes a skin disinfectant has also signi® - cantly reduced the infection rate with these microorganisms in various patient groups, including patients undergoing surgery (10, 28, 57), hemodialysis (33) and CAPD (10).”
BackgroundInfluentialHuang, Y.-C., Chou, Y.-H., Su, L.-H., Lien, R.-I., & Lin, T.-Y. (2006) · Pediatrics · doi:10.1542/peds.2006-0254 · Cited by 170
“51) Gestational age 28 wk 45 (14) 23 (5) .”
The ventilation of multiple-bed hospital wards: Review and analysis
Beggs, C. B., Kerr, K. G., Noakes, C. J., Hathway, E. A., & Sleigh, A. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.07.012 · Cited by 170
“S aureus often colonizes the anterior nares, with about 20% of healthy people having persistent nasal colonization and about 60% displaying intermittent carriage.(22) It appears that the nose acts as a reservoir, which then supports colonization of the skin surface of most carriers; eradication of staphylococci from t…”
Prevalence of Livestock-Associated MRSA in Communities with High Pig-Densities in The Netherlands
van Cleef, B. A. G. L., Verkade, E. J. M., Wulf, M. W. H., Buiting, A. G. M., Voß, A., Huijsdens, X. W., van Pelt, W., Mulders, M. N., & Kluytmans, J. A. J. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009385 · Cited by 170
“aureus (approximately 30% in the general population) might have lessoned this limitation of nasal selfswabbing [36].”
BackgroundSelf-citationLaupland, K. B., & Conly, J. M. (2003) · Clinical Infectious Diseases · doi:10.1086/377735 · Cited by 169
“aureus is common, it appears to be an important factor in the development of most infections due to this organism [2, 9, 10].”
BackgroundBacteria lacking a multidrug pump: A sensitive tool for drug discovery
Hsieh, P.-C., Siegel, S. A., Rogers, B., Davis, D., & Lewis, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6602 · Cited by 167
Mody, L., Kauffman, C. A., McNeil, S. A., Galecki, A. T., & Bradley, S. F. (2003) · Clinical Infectious Diseases · doi:10.1086/379325 · Cited by 167
Wilcox, M. H., Hall, J., Pike, H., Templeton, P. A., Fawley, W. N., Parnell, P., & Verity, P. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00147-6 · Cited by 166
Pan, E. S., Diep, B. A., Charlebois, E. D., Auerswald, C., Carleton, H. A., Sensabaugh, G. F., & Perdreau‐Remington, F. (2005) · The Journal of Infectious Diseases · doi:10.1086/432072 · Cited by 149
“aureus plays a key role in the epidemiology and pathogenesis of disease [15], we also examined the relation between MRSA genotypes from community-based nasal colonization and concurrent clinical isolates of CA-MRSA identified in local health-care facilities [11].”
BackgroundGorwitz, R. J. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815819bb · Cited by 164
“aureus has been identified as a risk factor for subsequent infection.(17) Few Accepted for publication August 10, 2007.”
BackgroundBlepharitis: current strategies for diagnosis and management
Jackson, W. B. (2008) · Canadian Journal of Ophthalmology · doi:10.3129/i08-016 · Cited by 164
Lu, P., Chin, L.-C., Peng, C., Chiang, Y.-H., Chen, T., Ma, L., & Siu, L.-K. K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.132-139.2005 · Cited by 164
“MRSA colonization may subsequently cause infections (7, 17, 40).”
BackgroundLysostaphin Cream Eradicates Staphylococcus aureus Nasal Colonization in a Cotton Rat Model
Kokai-Kun, J. F., Walsh, S. M., Chanturiya, T., & Mond, J. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1589-1597.2003 · Cited by 162
“One study (26) estimates the distribution of these carriers to be 20, 60, and 20%, respectively.”
BackgroundSevere infections emerge from commensal bacteria by adaptive evolution
Young, B. C., Wu, C.-H., Gordon, N. C., Cole, K., Price, J. R., Liu, E., Sheppard, A. E., Perera, S., Charlesworth, J., Golubchik, T., et al. (2017) · eLife · doi:10.7554/elife.30637 · Cited by 142
Deer, T. R., Provenzano, D. A., Hanes, M., Pope, J. E., Thomson, S. J., Russo, M. A., McJunkin, T., Saulino, M., Raso, L. J., Lad, S. P., et al. (2017) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/ner.12565 · Cited by 161
“aureus (MSSA) and MRSA are epidemiologically linked to a higher risk (two to nine times higher) for an SSI (67,69,70).”
BackgroundMantravadi, P. K., Kalesh, K., Dobson, R. C. J., Hudson, A. O., & Parthasarathy, A. (2019) · Antibiotics · doi:10.3390/antibiotics8010008 · Cited by 161
“aureus is a normal resident of human skin, and nasal cavity which can cause systemic sepsis if it enters the bloodstream [203].”
BackgroundMethicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance
Stefani, S., & Goglio, A. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.009 · Cited by 160
Detection and clinical relevance of Staphylococcus aureus nasal carriage: an update
Verhoeven, P. O., Gagnaire, J., Botelho-Nevers, E., Grattard, F., Carricajo, A., Lucht, F., Pozzetto, B., & Berthelot, P. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.859985 · Cited by 133
Smith, T. C., Gebreyes, W. A., Abley, M. J., Harper, A. L., Forshey, B. M., Male, M. J., Martin, H. W., Molla, B. Z., Sreevatsan, S., Thakur, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063704 · Cited by 159
“aureus, with the most common site for colonization being the anterior nares [1,2].”
BackgroundNasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery
Muñoz, P., Hortal, J., Giannella, M., Barrio, J. M., Rodríguez-Créixems, M., Pérez, M. J., Rincón, C., & Bouza, E. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.08.010 · Cited by 159
Phillips, M., Rosenberg, A., Shopsin, B., Cuff, G., Skeete, F., Foti, A., Kraemer, K., Inglima, K., Press, R., & Bosco, J. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676872 · Cited by 159
Kisich, K. O., Howell, M. D., Boguniewicz, M., Heizer, H. R., Watson, N. U., & Leung, D. Y. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700861 · Cited by 159
“Staphylococcus aureus is an important human pathogen, which can be isolated from the skin or nares of approximately 30% of the population (Kluytmans et al., 1997; Fridkin et al., 2005).”
BackgroundHuman Factor inStaphylococcus aureusNasal Carriage
Nouwen, J. L., Boelens, H. A. M., van Belkum, A., & Verbrugh, H. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6685-6688.2004 · Cited by 159
“Furthermore, host factors (7, 8, 10) as well as environmental factors are recognized determinants of the S.”
BackgroundSelf-citationImpact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery
Konvalinka, A., Errett, L. E., & Fong, I. W. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.010 · Cited by 158
Knight, G. M., Budd, E. L., Whitney, L., Thornley, A., Al-Ghusein, H., Planche, T., & Lindsay, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks245 · Cited by 158
André, M. C. D. P. B., Campos, M. R. H., Borges, L. J., Kipnis, A., Pimenta, F. C., & Serafini, Á. B. (2007) · Food Control · doi:10.1016/j.foodcont.2007.03.010 · Cited by 157
The Clonality of Staphylococcus aureus Nasal Carriage
Cespedes, C., Saïd‐Salim, B., Miller, M., Lo, S., Kreiswirth, B. N., Gordon, R. J., Vavagiakis, P., Klein, R. S., & Lowy, F. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/427240 · Cited by 140
“of the population [1, 2].”
Clonal Associations amongStaphylococcus aureusIsolates from Various Sites of Infection
Booth, M. C., Pence, L. M., Mahasreshti, P., Callegan, M. C., & Gilmore, M. S. (2001) · Infection and Immunity · doi:10.1128/iai.69.1.345-352.2001 · Cited by 157
“aureus for infection at other sites (22, 23).”
BackgroundAn Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureus
Reddy, P. N., Srirama, K., & Dirisala, V. R. (2017) · Infectious Diseases Research and Treatment · doi:10.1177/1179916117703999 · Cited by 156
Kisich, K. O., Carspecken, C. W., Fiévé, S., Boguniewicz, M., & Leung, D. Y. M. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.022 · Cited by 155
Rosales‐Mendoza, S., Paz-Maldonado, L. M. T., & Soria‐Guerra, R. E. (2011) · Plant Cell Reports · doi:10.1007/s00299-011-1186-8 · Cited by 154
Corvaglia, A. R., François, P., Hernandez, D., Perron, K., Linder, P., & Schrenzel, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000489107 · Cited by 131
“T opportunistic pathogen Staphylococcus aureus colonizes 20–50% of the human population (1, 2) and is responsible for a broad spectrum of human and animal diseases, ranging from benign skin infections to such severe diseases as osteomyelitis, endocarditis, and sepsis (3, 4).”
BackgroundDolosigranulum pigrum Cooperation and Competition in Human Nasal Microbiota
Brugger, S. D., Eslami, S. M., Pettigrew, M. M., Escapa, I. F., Henke, M. T., Kong, Y., & Lemon, K. P. (2020) · mSphere · doi:10.1128/msphere.00852-20 · Cited by 154
Thodis, E. D., Bhaskaran, S., Pasadakis, P. S., Bargman, J. M., Vas, S. I., & Oreopoulos, D. G. (1998) · Peritoneal Dialysis International · doi:10.1177/089686089801800304 · Cited by 152
(2007) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-007-0167-0 · Cited by 150
“-aureus- als auch A-Streptokokken-Besiedlungen transient oder persistent auftreten können [189, 194, 195] und dass zurzeit keine generell nachhaltig wirksamen Eradikationsprotokolle existieren.”
Background
Metadata
- Authors
- Kluytmans, J., van Belkum, A., & Verbrugh, H.
- Affiliations
- Ignatius Hospital (NL)
- Ignatius Hospital Breda, The Netherlands.
- ORCID
- Kluytmans, J
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1997-07
- Volume
- 10
- Issue
- 3
- Pages
- 505-520
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC172932
- OpenAlex
- W2111113492
- Cited by
- 2,595
- References
- 217
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 77 · 2023: 73 · 2022: 103 · 2021: 92 · 2020: 99 · 2019: 126 · 2018: 116 · 2017: 152 · 2016: 166 · 2015: 137 · 2014: 162 · 2013: 179 · 2012: 134
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- Staphylococcus aureus, nasal carriage, methicillin-resistant Staphylococcus aureus, persistent carriage, infection risk factors, hemodialysis, continuous ambulatory peritoneal dialysis, people who inject drugs, HIV infection, surgical patients, intravascular devices, infection control
- MeSH terms
- Bacterial Adhesion, Carrier State, Endothelium, Endothelium, Corneal, Epithelium, Renal Dialysis, Humans, Peritoneal Dialysis, Continuous Ambulatory, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Surgical Wound Infection, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.